WildBio
PrivateLast Round
Grant
Jun 2, 2025
Total Funding Raised
$25.71M
Company Overview
WildBio operates in Healthcare & Life Sciences and is based in Midrand. Its latest recorded funding round was a Grant round in June 2025.
WildBio is a biotechnology company that operates a cell biobank with a diverse array of African species cell lines, enabling the foodtech and biomedical sectors to create sustainable innovations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WildBio Comparables
Compare WildBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Livestock Laboratories & Biosciences | 78% | |
| Opo Bio | 78% | |
| Roslin Technologies | 77% |
For institutional investors. Book with your work email.
WildBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 2, 2025 | ||||
| Grant | Jul 1, 2021 |
For institutional investors. Book with your work email.
WildBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Seed |
| Oxford Science Enterprises | Seed |
| University of Oxford | Seed |
| Innovate UK | Grant |
| Advanced Research and Invention Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
$9.1M grant from Advanced Research and Invention Agency.
- Jul 1, 2021
$413K grant received from Innovate UK.
For institutional investors. Book with your work email.
WildBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WildBio's valuation, stock price, and market status.
Is WildBio a public or private company?
WildBio is a private company.
What is the current stock price of WildBio?
WildBio is a private company, so its shares have no public market price. Caplight tracks WildBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WildBio worth (valuation)?
Valuation information for WildBio is not publicly available.
Can I buy WildBio stock?
WildBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WildBio's last funding round?
WildBio's most recent funding round was Grant on June 2, 2025.
Who are the main investors in WildBio?
Key investors in WildBio include Braavos Investment Advisers, Oxford Science Enterprises, University of Oxford, Innovate UK, Advanced Research and Invention Agency.
Will WildBio IPO soon?
No public IPO plans have been announced for WildBio.
How can I track WildBio secondary market activity?
Caplight tracks bids, offers, and trades in WildBio's shares on secondary markets.